Published in Dtsch Arztebl Int on September 12, 2014
Does a complex intervention increase patient knowledge about oral anticoagulation? - a cluster-randomised controlled trial. BMC Fam Pract (2017) 0.75
Modern education, modern media: patient empowerment in today's medicine. Dtsch Arztebl Int (2014) 0.75
A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost (1993) 7.92
Consort 2010 statement: extension to cluster randomised trials. BMJ (2012) 7.47
A randomized trial of genotype-guided dosing of warfarin. N Engl J Med (2013) 7.18
A pharmacogenetic versus a clinical algorithm for warfarin dosing. N Engl J Med (2013) 7.09
Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg (2012) 5.49
A randomized trial of genotype-guided dosing of acenocoumarol and phenprocoumon. N Engl J Med (2013) 4.27
Risks of oral anticoagulant therapy with increasing age. Arch Intern Med (2005) 2.06
Do pharmacogenetics have a role in the dosing of vitamin K antagonists? N Engl J Med (2013) 2.00
Avoiding central nervous system bleeding during antithrombotic therapy: recent data and ideas. Stroke (2005) 1.85
Multimedia educational interventions for consumers about prescribed and over-the-counter medications. Cochrane Database Syst Rev (2013) 1.51
Safety of anticoagulation therapy in well-informed older patients. Arch Intern Med (2004) 1.36
Best strategies for patient education about anticoagulation with warfarin: a systematic review. BMC Health Serv Res (2008) 1.16
Written information about individual medicines for consumers. Cochrane Database Syst Rev (2009) 1.01
Assessing anticoagulation knowledge in patients new to warfarin therapy. Ann Pharmacother (2010) 0.97
Physicians' attitudes and the use of oral anticoagulants: surveying the present and envisioning future. J Thromb Thrombolysis (2004) 0.96
The gap between trial data and clinical practice -- an analysis of case reports on bleeding complications occurring under dabigatran and rivaroxaban anticoagulation. Cerebrovasc Dis (2013) 0.93
Self-management of oral anticoagulation. Dtsch Arztebl Int (2014) 0.91
Assessing bleeding risk in patients taking anticoagulants. J Thromb Thrombolysis (2013) 0.88
Self-management of oral anticoagulation in the elderly: rationale, design, baselines and oral anticoagulation control after one year of follow-up. A randomized controlled trial. Thromb Haemost (2007) 0.88
Practice nursed-based, individual and video-assisted patient education in oral anticoagulation--protocol of a cluster-randomized controlled trial. BMC Fam Pract (2011) 0.86
Patient knowledge on oral anticoagulants: results of a questionnaire survey in Germany and comparison with the literature. Int J Clin Pharmacol Ther (2008) 0.85
Supplemental patient education for patients taking oral anticoagulants: systematic review and meta-analysis. J Thromb Haemost (2013) 0.84
Novel oral anticoagulants in cardiovascular disease. J Cardiovasc Pharmacol Ther (2013) 0.80
Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy. Kidney Int (2011) 2.34
Automated electronic reminders to facilitate primary cardiovascular disease prevention: randomised controlled trial. Br J Gen Pract (2010) 2.32
Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis. Neurology (2005) 2.00
Platelets secrete stromal cell-derived factor 1alpha and recruit bone marrow-derived progenitor cells to arterial thrombi in vivo. J Exp Med (2006) 1.98
Mechanisms of Improved Exercise Performance under Hyperoxia. Respiration (2017) 1.94
Planning and analysis of three-arm non-inferiority trials with binary endpoints. Stat Med (2007) 1.54
Warwick-Edinburgh Mental Well-being Scale (WEMWBS): validated for teenage school students in England and Scotland. A mixed methods assessment. BMC Public Health (2011) 1.45
Robustness of methods for blinded sample size re-estimation with overdispersed count data. Stat Med (2013) 1.39
Telephone peer-delivered intervention for diabetes motivation and support: the telecare exploratory RCT. Patient Educ Couns (2008) 1.32
Nonmotor and diagnostic findings in subjects with de novo Parkinson disease of the DeNoPa cohort. Neurology (2013) 1.26
Pro-active call center treatment support (PACCTS) to improve glucose control in type 2 diabetes: a randomized controlled trial. Diabetes Care (2005) 1.20
A group-sequential design for clinical trials with treatment selection. Stat Med (2008) 1.20
Soluble glycoprotein VI dimer inhibits platelet adhesion and aggregation to the injured vessel wall in vivo. FASEB J (2003) 1.16
Simple procedures for blinded sample size adjustment that do not affect the type I error rate. Stat Med (2003) 1.13
Steroids as adjuvant therapy for acute pharyngitis in ambulatory patients: a systematic review. Ann Fam Med (2010) 1.08
A comparison of peritonitis in polycystic and non-polycystic patients on peritoneal dialysis. Perit Dial Int (2004) 1.03
Platelet GPVI binds to collagenous structures in the core region of human atheromatous plaque and is critical for atheroprogression in vivo. Basic Res Cardiol (2008) 0.99
Cross cultural evaluation of the Warwick-Edinburgh Mental Well-being Scale (WEMWBS) --a mixed methods study. Health Qual Life Outcomes (2013) 0.98
Sources of information and behavioral patterns in online health forums: observational study. J Med Internet Res (2014) 0.97
Anticholinergics for urinary symptoms in multiple sclerosis. Cochrane Database Syst Rev (2009) 0.96
Safety and Efficacy of the ACE-Inhibitor Ramipril in Alport Syndrome: The Double-Blind, Randomized, Placebo-Controlled, Multicenter Phase III EARLY PRO-TECT Alport Trial in Pediatric Patients. ISRN Pediatr (2012) 0.96
Photons and particles emitted from cold atmospheric-pressure plasma inactivate bacteria and biomolecules independently and synergistically. J R Soc Interface (2013) 0.92
Adaptive designs for confirmatory clinical trials with subgroup selection. J Biopharm Stat (2014) 0.91
Bladder symptoms in multiple sclerosis: a review of pathophysiology and management. Expert Opin Drug Saf (2010) 0.91
Appropriateness of treatment recommendations for PPI in hospital discharge letters. Eur J Clin Pharmacol (2010) 0.91
A novel adaptive design strategy increases the efficiency of clinical trials in secondary progressive multiple sclerosis. Mult Scler (2010) 0.90
Competence-based curriculum development for general practice in Germany: a stepwise peer-based approach instead of reinventing the wheel. BMC Res Notes (2013) 0.90
A comparison of methods for treatment selection in seamless phase II/III clinical trials incorporating information on short-term endpoints. J Biopharm Stat (2015) 0.88
Low back pain patient subgroups in primary care: pain characteristics, psychosocial determinants, and health care utilization. Clin J Pain (2014) 0.88
Time-patterns of annualized relapse rates in randomized placebo-controlled clinical trials in relapsing multiple sclerosis: a systematic review and meta-analysis. Mult Scler (2012) 0.88
Adhesion maturation of neutrophils on nanoscopically presented platelet glycoprotein Ibα. ACS Nano (2013) 0.87
Trends in annualized relapse rates in relapsing-remitting multiple sclerosis and consequences for clinical trial design. Mult Scler (2011) 0.87
Practice nursed-based, individual and video-assisted patient education in oral anticoagulation--protocol of a cluster-randomized controlled trial. BMC Fam Pract (2011) 0.86
Systematic review of randomized controlled trials of clinical prediction rules for physical therapy in low back pain. Spine (Phila Pa 1976) (2013) 0.86
Systematic review of clinical trials assessing the effectiveness of ivy leaf (hedera helix) for acute upper respiratory tract infections. Evid Based Complement Alternat Med (2010) 0.86
Blinded sample size re-estimation in crossover bioequivalence trials. Pharm Stat (2014) 0.84
Are fear-avoidance beliefs in low back pain patients a risk factor for low physical activity or vice versa? A cross-lagged panel analysis. Psychosoc Med (2009) 0.84
General practice-based clinical trials in Germany - a problem analysis. Trials (2012) 0.84
TTM-based motivational counselling does not increase physical activity of low back pain patients in a primary care setting--A cluster-randomized controlled trial. Patient Educ Couns (2007) 0.84
Early anemia and rapid virological response improve the predictive efficiency of IL28B-genotype for treatment outcome to antiviral combination therapy in patients infected with chronic HCV genotype 1. J Med Virol (2012) 0.84
Assessment of statistical significance and clinical relevance. Stat Med (2012) 0.83
Reporting FDR analogous confidence intervals for the log fold change of differentially expressed genes. BMC Bioinformatics (2011) 0.83
Explaining temporal trends in annualised relapse rates in placebo groups of randomised controlled trials in relapsing multiple sclerosis: systematic review and meta-regression. Mult Scler (2013) 0.83
The experience and management of neck pain in general practice: the patients' perspective. Eur Spine J (2010) 0.82
Efficacy of Ambroxol lozenges for pharyngitis: a meta-analysis. BMC Fam Pract (2014) 0.82
Assessing a risk tailored intervention to prevent disabling low back pain--protocol of a cluster randomized controlled trial. BMC Musculoskelet Disord (2010) 0.82
Concomitant and adjuvant temozolomide of newly diagnosed glioblastoma in elderly patients. Clin Neurol Neurosurg (2013) 0.81
Development of oral immunomodulatory agents in the management of multiple sclerosis. Drug Des Devel Ther (2011) 0.81
Biometrical journal and reproducible research. Biom J (2009) 0.80
Study protocol: improving patient choice in treating low back pain (IMPACT-LBP): a randomised controlled trial of a decision support package for use in physical therapy. BMC Musculoskelet Disord (2011) 0.80
Benefit of follow-up not confirmed. Dtsch Arztebl Int (2014) 0.80
Validation and reliability of the Neuropathic Pain Scale (NPS) in multiple sclerosis. Clin J Pain (2007) 0.80
Data-driven treatment selection for seamless phase II/III trials incorporating early-outcome data. Pharm Stat (2014) 0.80
Safety relevant knowledge of orally anticoagulated patients without self-monitoring: a baseline survey in primary care. BMC Fam Pract (2014) 0.80
Primum non nocere: shared informed decision making in low back pain--a pilot cluster randomised trial. BMC Musculoskelet Disord (2014) 0.79
Catching an entatic state--a pair of copper complexes. Angew Chem Int Ed Engl (2013) 0.79
Optical coherence tomography system mass-producible on a silicon photonic chip. Opt Express (2016) 0.79
Scientific Versus Experiential Evidence: Discourse Analysis of the Chronic Cerebrospinal Venous Insufficiency Debate in a Multiple Sclerosis Forum. J Med Internet Res (2015) 0.79
Perspectives on the use of adaptive designs in clinical trials. Part II. Panel discussion. J Biopharm Stat (2010) 0.79
Interleukin-2 receptor antagonists for pediatric liver transplant recipients: a systematic review and meta-analysis of controlled studies. Pediatr Transplant (2014) 0.79
Five-year outcomes from a trial of three limus-eluting stents with different polymer coatings in patients with coronary artery disease: final results from the ISAR-TEST 4 randomised trial. EuroIntervention (2016) 0.79
Frequency and perceived severity of negative experiences during medical education in Germany--results of an online-survery of medical students. GMS Z Med Ausbild (2012) 0.79
Effectiveness of varenicline as an aid to smoking cessation in primary care: an observational study. Eur Addict Res (2012) 0.78
Design and semiparametric analysis of non-inferiority trials with active and placebo control for censored time-to-event data. Stat Med (2013) 0.78
Blinded assessment of treatment effects utilizing information about the randomization block length. Stat Med (2009) 0.78
Teaching in practice: a survey of a general practice teaching network. Med Teach (2006) 0.78
The poorly membrane permeable antipsychotic drugs amisulpride and sulpiride are substrates of the organic cation transporters from the SLC22 family. AAPS J (2014) 0.77
Therapeutic apheresis in pediatric patients with acute CNS inflammatory demyelinating disease. Blood Purif (2013) 0.77
Effects of verbal suggestion on coronary arteries: results of a randomized controlled experimental investigation during coronary angiography. Am Heart J (2011) 0.77
Vitamin d deficiency reduces the immune response, phagocytosis rate, and intracellular killing rate of microglial cells. Infect Immun (2014) 0.77
Considerations on what constitutes a 'qualified statistician' in regulatory guidelines. Stat Med (2011) 0.77
Optimal choice of the number of treatments to be included in a clinical trial. Stat Med (2009) 0.77
Design and development of a decision support package for low back pain. Arthritis Care Res (Hoboken) (2014) 0.76
CD4+ lymphocyte adenosine triphosphate--a new marker in sepsis with acute kidney injury? BMC Nephrol (2014) 0.75
WITHDRAWN: Anticholinergics for urinary symptoms in multiple sclerosis. Cochrane Database Syst Rev (2015) 0.75
Spline-based procedures for dose-finding studies with active control. Stat Med (2014) 0.75
The effect of cardiopulmonary bypass and hypothermic circulatory arrest on hepatic histology in newborn animals: an experimental study. Artif Organs (2013) 0.75
Imaging for low-back pain. Lancet (2009) 0.75
Renal failure after renal sympathetic ablation in a patient with chronic kidney disease--which came first, the chicken or the egg? Int J Cardiol (2013) 0.75
["No evidence that the benefits outweight the damage"]. MMW Fortschr Med (2015) 0.75
An Unconditional Test for Change Point Detection in Binary Sequences with Applications to Clinical Registries. Methods Inf Med (2016) 0.75
Effect of the left internal mammary artery to the left anterior descending artery on mortality and morbidity after combined coronary and valve operations. Ann Thorac Surg (2005) 0.75
Power and sample size determination when assessing the clinical relevance of trial results by 'responder analyses'. Stat Med (2004) 0.75
Impact of stent size on angiographic and clinical outcomes after implantation of everolimus-eluting bioresorbable scaffolds in daily practice: insights from the ISAR-ABSORB registry. EuroIntervention (2016) 0.75
Fast gain recovery rates with strong wavelength dependence in a non-linear SOA. Opt Express (2010) 0.75
Blinded and unblinded internal pilot study designs for clinical trials with count data. Biom J (2013) 0.75